Financial hardship after hematopoietic cell transplantation: Lack of impact on survival

Nandita D Khera, Randy Albelda, Theresa Hahn, Diana Salas Coronado, Oreofe O. Odejide, Robert J. Soiffer, Gregory A. Abel

Research output: Contribution to journalArticle

Abstract

Background: Financial hardship is a growing challenge for patients with blood cancer who undergo hematopoietic cell transplantation (HCT), and it is associated with poor patient-reported outcomes. In contrast, little is known about the potential impact of patient-reported financial hardship on post-HCT survival. Methods: We sought to describe the association of financial hardship with survival after HCT in a prospectively assembled cohort of patients from three large transplant centers (n = 325). Results: There was no association between financial hardship measures assessed at 6 months post-HCT and 1- or 2-year survival after HCT. Conclusions: Patient-reported financial distress after HCTdoes not seem to adversely affect post-HCT survival. Impact: When assessing the effectiveness of interventions to ameliorate familial financial burden among HCT, the focus should be on patient-reported outcomes rather than survival.

Original languageEnglish (US)
Pages (from-to)345-347
Number of pages3
JournalCancer Epidemiology Biomarkers and Prevention
Volume27
Issue number3
DOIs
StatePublished - Mar 1 2018

    Fingerprint

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this